# Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

> **NCT07190027** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 246 (estimated)

## Conditions studied

- Advanced Non-Small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Arm 1： Standard Synchronous Group
- **DRUG:** Arm 2：Fixed Delay Group
- **DRUG:** Arm 3： Individualized Delay Group

## Key facts

- **NCT ID:** NCT07190027
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2025-11
- **Final completion:** 2028-11
- **Target enrollment:** 246 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190027, "Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07190027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*